RVL Pharmaceuticals plc announces Insider and Athyrium-Led
-- Obtained $68.9 million in committed financing through a combination of equity and non-dilutive debt financing -- -- The cash trail is expected to extend through 2023 with $43.9 million funded at close and an additional $25.0 million…